The four UK health systems

In theory, this divergence should offer a unique opportunity to establish ‘what works’ in these different approaches. In practice, the exercise is hampered by hard-to-compare data and a political reluctance to back comparative studies.

Much more could be done to facilitate such studies. To this end, the paper explores devolution, finance and politics, documenting areas that diverge and those where cross-border transfer of policy has occurred. It concludes by listing opportunities for cross-border learning that are being ignored.

Key findings

• Learning between the different systems has occurred, albeit indirectly and despite great reluctance to share knowledge. But many more opportunities for cross-border learning are being missed and each government must strive to make data more comparable.
• All four countries face the same basic issues – severe financial pressure; flat or declining rates of spending; pressures from technological advance, an ageing society, obesity and other health problems. There is broad consensus on moving more care out of hospital and into communities, implying a significant reconfiguration of hospitals in each nation.
• England’s adherence to and extension of market-like mechanisms in managing health differentiates it most dramatically from the other three services – which characterise themselves as having learned what not to do from the English experience.
• Use of targets is an obvious example of lessons learnt. Devolved nations overcame their initial reluctance about them, once English waiting times fell sharply after targets were introduced.

Policy implications

• Lack of timely and genuinely comparable data means that it is hard to say which country is getting better value for money from its health service. The four health departments should therefore agree specific indicators, establish which data is needed to make comparisons and identify how best to collect that data.
• More comparable data could over time help determine whether competition is producing better or worse outcomes than more consensual, partnership-type approaches. It could also potentially answer smaller but vital questions related to organising clinical care, methods for integrating care, the merits of abolishing prescription charges among others. 
• In the absence of such data, academics and others should do whatever is possible with what is available.